Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
79.2M
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
54.6M
-
Shares change
-
+29M
-
Total reported value, excl. options
-
$414M
-
Value change
-
+$230M
-
Put/Call ratio
-
0.28
-
Number of buys
-
55
-
Number of sells
-
-18
-
Price
-
$7.58
Significant Holders of Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) as of Q4 2020
94 filings reported holding SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share as of Q4 2020.
Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.6M shares
of 79.2M outstanding shares and own 68.93% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (10.8M shares), RA CAPITAL MANAGEMENT, L.P. (9.98M shares), EcoR1 Capital, LLC (7.98M shares), Bain Capital Life Sciences Investors, LLC (7.06M shares), BOXER CAPITAL, LLC (4.23M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (4.05M shares), BlackRock Inc. (2M shares), VANGUARD GROUP INC (1.68M shares), MILLENNIUM MANAGEMENT LLC (841K shares), and Ikarian Capital, LLC (788K shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.